IRIS Accounts Production v23.4.0.336 00555128 Board of Directors Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh005551282022-12-31005551282023-12-31005551282023-01-012023-12-31005551282021-12-31005551282022-01-012022-12-31005551282022-12-3100555128ns15:EnglandWales2023-01-012023-12-3100555128ns14:PoundSterling2023-01-012023-12-3100555128ns10:Director12023-01-012023-12-3100555128ns10:Director22023-01-012023-12-3100555128ns10:CompanyLimitedByGuarantee2023-01-012023-12-3100555128ns10:SmallEntities2023-01-012023-12-3100555128ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3100555128ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3100555128ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3100555128ns10:FullAccounts2023-01-012023-12-3100555128ns10:Director32023-01-012023-12-3100555128ns10:Director42023-01-012023-12-3100555128ns10:Director62023-01-012023-12-3100555128ns10:Director72023-01-012023-12-3100555128ns10:Director82023-01-012023-12-3100555128ns10:Director92023-01-012023-12-3100555128ns10:Director102023-01-012023-12-3100555128ns10:Director112023-01-012023-12-3100555128ns10:Director122023-01-012023-12-3100555128ns10:CompanySecretary12023-01-012023-12-3100555128ns10:RegisteredOffice2023-01-012023-12-3100555128ns5:CurrentFinancialInstruments2023-12-3100555128ns5:CurrentFinancialInstruments2022-12-3100555128ns5:FurtherSpecificReserve1ComponentTotalEquity2023-12-3100555128ns5:FurtherSpecificReserve1ComponentTotalEquity2022-12-3100555128ns5:RetainedEarningsAccumulatedLosses2023-12-3100555128ns5:RetainedEarningsAccumulatedLosses2022-12-3100555128ns5:PlantMachinery2023-01-012023-12-3100555128ns5:FurnitureFittings2023-01-012023-12-3100555128ns5:MotorVehicles2023-01-012023-12-3100555128ns5:PlantMachinery2022-12-3100555128ns5:FurnitureFittings2022-12-3100555128ns5:MotorVehicles2022-12-3100555128ns5:ComputerEquipment2022-12-3100555128ns5:ComputerEquipment2023-01-012023-12-3100555128ns5:PlantMachinery2023-12-3100555128ns5:FurnitureFittings2023-12-3100555128ns5:MotorVehicles2023-12-3100555128ns5:ComputerEquipment2023-12-3100555128ns5:PlantMachinery2022-12-3100555128ns5:FurnitureFittings2022-12-3100555128ns5:MotorVehicles2022-12-3100555128ns5:ComputerEquipment2022-12-3100555128ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3100555128ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3100555128ns5:CurrentFinancialInstruments2023-01-012023-12-3100555128ns5:WithinOneYear2023-12-3100555128ns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 00555128 (England and Wales)















The Institute of Podiatrists

Unaudited Financial Statements for the Year Ended 31 December 2023






The Institute of Podiatrists (Registered number: 00555128)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


The Institute of Podiatrists

Company Information
for the Year Ended 31 December 2023







DIRECTORS: Mr A Ali
Mr M Harvey
Ms H M Jephcote
Mr S Miah
Ms B J Wright
Ms C L Mccartney
Mr S T Preston
Mr W J Liggins
Mr J Olivelle
Mr A Williams
Mrs G Wooldridge





SECRETARY: Miss A J Burnett Hurst





REGISTERED OFFICE: 150 Lord Street
Southport
Merseyside
PR9 0NP





REGISTERED NUMBER: 00555128 (England and Wales)





ACCOUNTANTS: Advance Chartered Certified Accountants
71-73 Hoghton Street
Southport
Merseyside
PR9 0PR

The Institute of Podiatrists (Registered number: 00555128)

Balance Sheet
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 9,366 11,049
Investments 6 7 7
9,373 11,056

CURRENT ASSETS
Stocks 7 11,611 7,254
Debtors 8 49,793 27,788
Cash at bank 545,278 597,841
606,682 632,883
CREDITORS
Amounts falling due within one year 9 218,008 177,952
NET CURRENT ASSETS 388,674 454,931
TOTAL ASSETS LESS CURRENT
LIABILITIES

398,047

465,987

RESERVES
Other reserves 20,557 20,557
Income and expenditure account 377,490 445,430
398,047 465,987

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The Institute of Podiatrists (Registered number: 00555128)

Balance Sheet - continued
31 December 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 February 2024 and were signed on its behalf by:




Mr M Harvey - Director



Mr S Miah - Director


The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

The Institute of Podiatrists is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Income
The income shown in the Income and Expenditure Account is derived from the ordinary activity of the company, which is that of operating a professional institute for chiropodists, podiatrists and foot health practitioners and providing related training services, and represents income during the year exclusive of Value Added Tax.

The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

3. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computers and fax machine - 33% on cost and 15% on reducing balance
Furniture and equipment - 33% on cost and 15% on reducing balance
Education equipment - 15% on reducing balance

No depreciation is provided on the Institute's President's Chain of Office as the chain of office is not considered to be a depreciable asset.

Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. ·

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in income and expenditure, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate o.fits recoverable amount. but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in income and expenditure, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are stated at the lower of cost and net realisable value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The company operates a deferred contribution retirement benefit scheme for the benefit of its employees. Contributions are expensed as they become payable.

The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short term liquid investments with other maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

3. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial instruments

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in income and expenditure, except that investments in equity instruments that are not publically traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through income and expenditure, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in income and expenditure.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in income and expenditure.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification or financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

3. ACCOUNTING POLICIES - continued

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in income and expenditure in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

Debt instruments that do not meet the conditions in FRS I 02 paragraph 11.9 are subsequently measured at fair value through income and expenditure. Debt instruments may be designated as being measured at fair value though income and expenditure to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Leases

Assets acquired under finance leases are capitalised and depreciated over the shorter of the lease term and the expected useful life of the asset. Minimum lease payments are apportioned between the finance charge and the reduction of the outstanding lease liability using the effective interest method. The related obligations. net of future finance charges, are included in creditors.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

Rentals payable under operating leases, including any lease incentives received, are charged to the income and expenditure account on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

5. TANGIBLE FIXED ASSETS
Computers Furniture
and fax and Education Chain of
machine equipment equipment office Totals
£    £    £    £    £   
COST
At 1 January 2023
and 31 December 2023 6,455 57,789 4,347 1,580 70,171
DEPRECIATION
At 1 January 2023 6,401 49,210 3,511 - 59,122
Charge for year 8 1,550 125 - 1,683
At 31 December 2023 6,409 50,760 3,636 - 60,805
NET BOOK VALUE
At 31 December 2023 46 7,029 711 1,580 9,366
At 31 December 2022 54 8,579 836 1,580 11,049

6. FIXED ASSET INVESTMENTS

The company owns the whole of the issued share capital of the following dormant companies incorporated in England and Wales:

College of Foot Health Limited
College of Podiatric Doctors Ltd
International College of Podiatric Doctors Ltd
The Faculty of Podiatric Medicine Limited
The College of Podiatric Surgeons Limited
The Faculty of Forensic and Medico-Legal Podiatry Ltd
The College of Forensic and Medico-Legal Podiatry Ltd

7. STOCKS

20232022
£   £   
Badges of merit2,0191,129
Stationery753905
Education303286
Sundry sale items00
Stock in trade1,054916
Promotional item4,4604,018
3TO stock3,0220
11,6107,254

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 35,498 16,750
Other debtors 14,295 11,038
49,793 27,788

The Institute of Podiatrists (Registered number: 00555128)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 2,481 2,134
Other creditors 215,527 175,818
218,008 177,952

During the 2018 year end negative goodwill arising on the merger with the Associated Chiropodists and Podiatrists Union was transferred to other creditors. The balance transferred of £7,943 continues to be credited to the income and expenditure account over the remaining period in which the directors feel the Institute will derive benefit from the merger. As at 31 December 2023, the balance included within other creditors was £2,983.

10. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2023 2022
£    £   
Within one year 27,000 27,000

11. RELATED PARTY DISCLOSURES

During the year the Institute received services from Mr S Miah, a director of the company, totalling £7,627.20 (2022 - £9,893.44).

During the year the Institute received services from Mr M Harvey, a director of the company, totalling £11,689.45 (2022- £10,111.38).

12. SHARE CAPITAL

The Institute of Chiropodists and Podiatrists is a company limited by guarantee, and therefore does not have share capital. The extent of each subscriber's liability is limited to a maximum of £1.